Morning Briefing
Summaries of health policy coverage from major news organizations
FDA Approves 100th Antiretroviral For PEPFAR
HHS recently announced the FDA's 100th approval of an antiretroviral drug for PEPFAR, PharmTech.com reports. Seventy-one of the more than 100 drugs reviewed by FDA for PEPFAR were generic products. HHS Secretary Kathleen Sebelius said in a statement, "This milestone exemplifies the dedication, caring, and hard work of all who strive to better the lives of those infected with or affected by HIV/AIDS" (10/15).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
